News & Events about Shockwave Medical Inc.
Neovascs Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market Shockwave Medical Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Full Year 2023 Revenue Guidance SANTA CLARA, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (...
ShockWave Medical, Inc. (NASDAQ:SWAV Get Rating) Director Frank T. Watkins sold 10,000 shares of ShockWave Medical stock in a transaction dated Monday, January 9th. The stock was sold at an average price of $203.73, for a total value of $2,037,300.00. Following the completion of the sale, the ...
ShockWave Medical, Inc. (NASDAQ:SWAV Get Rating) insider Isaac Zacharias sold 4,000 shares of the companys stock in a transaction on Friday, November 25th. The stock was sold at an average price of $261.82, for a total value of $1,047,280.00. Following the sale, the insider now owns ...
Globe Newswire
2 months ago
SANTA CLARA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in the Piper Sandler 34th Annual ...
Ticker Report
2 months ago
ShockWave Medical, Inc. (NASDAQ:SWAV Get Rating) Director Frank T. Watkins sold 3,000 shares of the businesss stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $244.44, for a total transaction of $733,320.00. Following the completion of the...